MedImmune Message Board - Msg: 17723799

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (232)	7/11/2002 2:37:09 PM
From: Edscharp	of 416

Got this email alert from Schwab today. Charles Schwab & Co., Inc. Email Alert News Alert Thursday, July 11, 2002 Information provided by Reuters Although the FDA decision on FluMist was expected yesterday, MEDIMMUNE INC. (21.10 @ yesterday's close) has not issued any press release regarding a response from the FDA. Salomon Smith Barney believes that the most likely scenario is that the company has received a "complete response" letter from the FDA, and that Medimmune may be evaluating any outstanding issues in the FDA response to determine whether the drug is likely to be approved this year. The firm continues to believe the product is approvable but the timing of approval is difficult to predict. [Briefing.com]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next